U.S. markets closed

Advaxis, Inc. (ADXS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.4011+0.0291 (+7.82%)
At close: 4:00PM EDT

Advaxis, Inc.

305 College Road East
Princeton, NJ 08540
United States
609 452 9813
http://www.advaxis.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees17

Key Executives

NameTitlePayExercisedYear Born
Mr. Kenneth A. Berlin J.D.Pres, Interim CFO, CEO & Director1.16MN/A1964
Dr. Andres A. GutierrezExec. VP & Chief Medical Officer624.26kN/A1961
Mr. Igor Gitelman CPA, M.B.A., CPA, MBAChief Accounting Officer & VP of Fin.N/AN/A1976
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. The company has collaborations and partnerships with Merck & Co., Inc.; OS Therapies, LLC; Aratana Therapeutics Inc.; Biocon Limited; Global BioPharma Inc.; Knight Therapeutics Inc; and others. Advaxis, Inc. was founded in 2002 and is based in Princeton, New Jersey.

Corporate Governance

Advaxis, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.